Physician

Family Medicine

Lynette Rogers works in the field of Family Medicine. Lynette Rogers, MD is also a published doctor. He has 50 paper published. The most recent paper is: Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice. He accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Tobacco Metabolites and Caffeine in Human Milk Purchased via the Internet.
• Plasma Asymmetric Dimethylarginine Levels Are Increased in Neonates with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
• Stress adaptation and the resilience of youth: fact or fiction?
• The Thioredoxin Reductase-1 Inhibitor Aurothioglucose Attenuates Lung Injury and Improves Survival in a Murine Model of Acute Respiratory Distress Syndrome.
• Perinatal Inflammation Results in Decreased Oligodendrocyte Numbers in Adulthood.
• Glutathione Reductase Is Essential for Host Defense against Bacterial Infection.
• Randomized controlled trial of docosahexaenoic Acid supplementation in midwestern u.s. Human milk donors.
• DHA supplementation: Current implications in pregnancy and childhood.
• Measurement of arginine metabolites: regulators of nitric oxide metabolism.
• Associations between Maternal and Infant Morbidities and sRAGE within the First Week of Life in Extremely Preterm Infants.
• Neonatal hyperoxic exposure persistently alters lung secretoglobins and annexin A1.
• Development of cholesterol homeostatic memory in the rat is influenced by maternal diets.
• Selective modification of apoB-100 in the oxidation of low density lipoproteins by myeloperoxidase in vitro.
• Acetaminophen binds to mouse hepatic and renal DNA at human therapeutic doses.
• Oxidation of bovine beta-casein by hypochlorite.
• Diquat- and acetaminophen-induced alterations of biliary efflux of iron in rats.
• Attenuation of acetaminophen hepatotoxicity in mice as evidence for the bioavailability of the cysteine in D-glucose-L-cysteine in vivo.
• Effects of hepatotoxic doses of acetaminophen and furosemide on tissue concentrations of CoASH and CoASSG in vivo.
• Early amino-acid administration improves preterm infant weight.
• Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice.
• Biliary excretion of lysosomal enzymes, iron, and oxidized protein in Fischer-344 and Sprague-Dawley rats and the effects of diquat and acetaminophen.
• Mitochondrial thiol status in the liver is altered by exposure to hyperoxia.
• Glutathione Reductase Facilitates Host Defense by Sustaining Phagocytic Oxidative Burst and Promoting the Development of Neutrophil Extracellular Traps.
• A dietary approach to increase in-stent stenosis and face validity of a rat model for arterial angioplasty and stenting.
• Systemic maternal inflammation and neonatal hyperoxia induces remodeling and left ventricular dysfunction in mice.
• Maternal inflammation, growth retardation, and preterm birth: insights into adult cardiovascular disease.
• Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice.
• Riboflavin supplementation does not attenuate hyperoxic lung injury in transgenic (spc-mt)hGR mice.
• Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine.
• Docosahexaenoic Acid and Amino Acid Contents in Pasteurized Donor Milk are Low for Preterm Infants.
• Thioredoxin-interacting protein inhibits hypoxia-inducible factor transcriptional activity.
• Antiretrovirals induce endothelial dysfunction via an oxidant-dependent pathway and promote neointimal hyperplasia.
• Inhaled nitric oxide prevents 3-nitrotyrosine formation in the lungs of neonatal mice exposed to >95% oxygen.
• Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure.
• Hyperoxia exposure alters hepatic eicosanoid metabolism in newborn mice.
• Alterations of the thioredoxin system by hyperoxia: implications for alveolar development.
• Differential responses in the lungs of newborn mouse pups exposed to 85% or >95% oxygen.
• Glutathione reductase targeted to type II cells does not protect mice from hyperoxic lung injury.
• Altered expressions of fibroblast growth factor receptors and alveolarization in neonatal mice exposed to 85% oxygen.
• Thioredoxin-related mechanisms in hyperoxic lung injury in mice.
• Diquat induces renal proximal tubule injury in glutathione reductase-deficient mice.
• Detection of reversible protein thiol modifications in tissues.
• Hyperoxia increases hepatic arginase expression and ornithine production in mice.
• Analyses of glutathione reductase hypomorphic mice indicate a genetic knockout.
• Compartmental inhibition of hepatic glutathione reductase activities by 1,3-bis(2-chloroethyl)-N-nitrosourea (BCNU) in Sprague-Dawley and Fischer-344 rats.
• Stable transfection of Chinese hamster ovary cells with glutamate-cysteine ligase catalytic subunit cDNA confers increased resistance to tert-butyl hydroperoxide toxic...
• Nuclear and nucleolar glutathione reductase, peroxidase, and transferase activities in livers of male and female Fischer-344 rats.
• Effects of fasting on tissue contents of coenzyme A and related intermediates in rats.
• CoASH and CoASSG levels in lungs of hyperoxic rats as potential biomarkers of intramitochondrial oxidant stresses.

Schools

---

• Sydney University

• Queens Mediacal Center

• Queen39s Med Center

Doctors Specialties

---

• Family Medicine

Accepted Insurances

---

• Choice Plus POS II
• Pathway X Tier Hosp HealthKeepers DirectAccess VA
• HealthKeepers HMO
• KeyCare PPO
• Blue Card PPO
• Cigna HMO
• Cigna PPO
• Great West Healthcare-Cigna PPO
• Open Access Plus
• CoreSource
• Southern Health PPO
• First Health (Coventry Health Care) PPO
• Choice Care PPO
• Mail Handlers Benefit Plan (MHBP)
• Medicare MCR
• MultiPlan PPO
• Choice Plus POS
• Navigate HMO
• Navigate POS
• Options PPO
• Universal American

Education

---

• University of Sydney Faculty of Medicine

Drug Facts

---

NPI NUMBER		1356317176
NPPES Provider LastName		ROGERS
NPPES Provider FirstName		LYNETTE
NPPES Provider ZIPCode		235183801
NPPES Provider State		VA
Specialty Description		Family Practice
Total Claim Count		109.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1356317176
Last Name Of The Provider	ROGERS
First Name Of The Provider	LYNETTE
View All

Similar Doctors

---

	Dr. Jonah R. Flowers, DO This Doctor is OpenDoctor Recommended.
	Dr. Randall C. Fedro, MD This Doctor is OpenDoctor Recommended.
	Dr. Richard Sams II, MD This Doctor is OpenDoctor Recommended.
	Dr. Sean P. Leonard, MD This Doctor is OpenDoctor Recommended.
	Dr. Hetal N. Gandhi, MD This Doctor is OpenDoctor Recommended.
	Dr. Fatma R. Masoud, MD This Doctor is OpenDoctor Recommended.
	Dr. Zain Javed, MD This Doctor is OpenDoctor Recommended.
	Dr. Daniel B. Algert, MD
	Dr. Robert R. Enloe, DO
	Dr. Chantal N. Afuh, MD
	Dr. Alin V. Ledford, MD
	Dr. Eric B. Michel, DO
	Dr. Reymond D. Pascual, MD This Doctor is OpenDoctor Recommended.
	Dr. Fred E. Kency Jr., MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog